Clinical Trials Logo

Clinical Trial Summary

Postoperative pain is a major problem in patients who either donate a kidney or undergo kidney transplantation. This pain is commonly treated with opioids, which can cause several side effects, ranging from pruritus, impaired vigilance, and most concerning to severe respiratory depression. This can be aggravated in the recipient by accumulation of opioid metabolites secondary to renal impairment and secretion.

Several studies have shown an opioid sparing effect of a transversus abdominis plane (TAP) block after surgery in the lower abdomen. In the proposed study, we plan to compare the impact of an ultrasound guided single shot transversus abdominis plane (TAP) block versus a ultrasound guided sham block with normal saline (placebo) on postoperative pain scores, postoperative opioid consumption, as well as patient's satisfaction.

The investigators hypothesize, that patients who receive a TAP block will have lower postoperative pain scores, lower postoperative opioid consumption as well as higher satisfaction scores.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01496729
Study type Interventional
Source University of California, San Francisco
Contact
Status Withdrawn
Phase N/A
Start date January 2012
Completion date January 2013

See also
  Status Clinical Trial Phase
Completed NCT00189735 - A Study to Evaluate FK778 in Kidney Transplant Patients Phase 2
Recruiting NCT01150487 - Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients N/A
Completed NCT01656343 - Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
Completed NCT02625428 - IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys? Phase 4
Not yet recruiting NCT00617474 - The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group Phase 1
Terminated NCT00365833 - CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients N/A
Completed NCT00861536 - Comparison of ATG to Thymoglobuline in Renal Transplantation Phase 4
Completed NCT00614081 - GFR Measurement With Contrast-enhanced Dynamic MRI N/A
Completed NCT03977051 - Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
Terminated NCT00568477 - Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation Phase 2
Completed NCT04874740 - Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
Available NCT01236287 - Special Access for the Use of Voclosporin for Kidney Transplantation